Affymetrix GeneChip Arrays Elevated In Roche Pact, Considered By FDA

Affymetrix' plans to establish its GeneChip as the standard platform technology for genomics-based diagnostics are bolstered by FDA enthusiasm for the probe microarrays, the company claims

More from Archive

More from Medtech Insight